Search Results - pulmonology+pharma

1 Results Sort By:
Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis
Reference #: 01409 The University of South Carolina is offering licensing opportunities for Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis Background: Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effects...
Published: 9/4/2022   |   Inventor(s): Michael Wyatt, Chloe LeBegue
Keywords(s): bleomycin, bleomycin hydrolase, enzyme, inhaled, protein, pulmonary fibrosis, pulmonary toxicity, pulmonology biotech, pulmonology pharma
Category(s): Chemistry and Biochemistry, Health Sciences